| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |